패혈증 시장 규모는 향후 몇 년간 강력한 성장이 전망될 예정입니다. 중환자 치료 분야에서 인공지능 채용 증가, 다제 내성 감염의 만연, 패혈증에 대한 계몽 활동 확대, 신흥 국가의 건강 관리 인프라 확대, 생명 공학 및 제약 연구에 대한 투자 증가 등에 기인한다고 생각됩니다. 예측 기간에 있어서의 주요한 동향으로서는 신속한 POC(Point of Care) 진단의 개발, AI를 활용한 예측 분석의 도입, 개별화된 항생제 스튜어드십 프로그램, 혈액 배양 기술의 진보, 혁신적인 바이오마커의 동정, 면역 조절을 표적으로 한 신규 치료법의 개발 등을 들 수 있습니다.
감염의 확산은 향후 몇 년 동안 패혈증 시장의 확대를 촉진할 것으로 예측됩니다. 일반적인 예로는 결핵, 인플루엔자, 백선, 말라리아 등이 있습니다. 세계화, 환경 변화, 약물 내성 병원체, 의료 시스템의 격차 등 여러 요인이 감염병 발생률 증가에 기여하고 있습니다.감염의 심각한 합병증인 패혈증은 신체의 극단적인 반응으로 인해 광범위하게 염증을 일으켜 장기 부전에 빠질 수 있습니다. 2024년 11월에 미국 질병통제예방센터는 2023년 미국에서 9,633건의 결핵 환자가 보고되어 2022년에 보고된 8,332건에서 15.6% 증가했다고 보고했습니다.
패혈증 시장의 기업은 인공지능(AI)을 탑재한 플랫폼 등의 첨단기술을 활용하여 조기진단 개선, 치료정밀도 향상, 환자의 결과 예측을 실시했습니다. Group(HPG)은 패혈증의 조기 징후를 검출하는 웨어러블 바이오센서를 통합한 AI 탑재 진단 플랫폼 OpenDX를 발표했습니다. 진단에 있어서 AI의 역할이 증가하고 있음을 강조하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 패혈증 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 패혈증 시장 : 성장률 분석
- 세계의 패혈증 시장 실적 : 규모와 성장, 2019-2024
- 세계의 패혈증 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 패혈증 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 패혈증 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 진단
- 치료제
- 세계의 패혈증 시장 : 병원체별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세균성
- 바이럴
- 곰팡이
- 세계의 패혈증 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 심한 패혈증
- 패혈증성 쇼크
- 세계의 패혈증 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 병리학
- 레퍼런스 랩
- 세계의 패혈증 시장 : 진단별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 혈액검사
- 화상 기술
- 미생물학적 배양 검사
- 바이오마커 검사
- 기타 진단 방법
- 세계의 패혈증 시장 : 치료제유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 항생제
- 항진균제
- 혈관 수축제
- 면역글로불린
- 코르티코스테로이드
- 기타 치료 옵션
제7장 지역별/국가별 분석
- 세계의 패혈증 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 패혈증 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 패혈증 시장 : 경쟁 구도
- 패혈증 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Abbott laboratories
- Novartis AG
- Siemens AG
- Asahi Kasei Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- QuidelOrtho Corporation
- Diasorin SpA
- Innoviva Inc.
- Seegene Inc.
- EKF Diagnostics
- Boditech Med Inc.
- Cytovale Inc.
- Alifax Srl
- Hansa Biopharma
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 패혈증 시장(2029년) : 새로운 기회를 제공하는 국가
- 패혈증 시장(2029년) : 새로운 기회를 제공하는 부문
- 패혈증 시장(2029년) : 성장 전략
제36장 부록
SHW
Sepsis is a life-threatening condition resulting from the body's extreme response to an infection. It occurs when the immune system releases chemicals into the bloodstream to combat the infection, but these chemicals trigger widespread inflammation, leading to tissue damage, organ failure, and potentially death.
The primary aspects of sepsis management include diagnosis and therapeutics. Diagnosis focuses on detecting sepsis through various tests and procedures that identify infections and assess their severity. The condition can be caused by pathogens such as bacteria, viruses, and fungi. Sepsis-related applications include severe sepsis and septic shock, with utilization in hospitals, pathology labs, and reference laboratories.
The sepsis market research report is one of a series of new reports from The Business Research Company that provides sepsis market statistics, including the sepsis industry's global market size, regional shares, competitors with a sepsis market share, detailed sepsis market segments, market trends and opportunities, and any further data you may need to thrive in the sepsis industry. This sepsis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sepsis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the increasing incidence of sepsis due to aging populations, the rising prevalence of chronic diseases, greater awareness of sepsis among healthcare providers, escalating healthcare expenditures, and the implementation of government initiatives for early detection and management.
The sepsis market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the increasing adoption of artificial intelligence in critical care, the rising prevalence of multidrug-resistant infections, growing awareness campaigns about sepsis, expanding healthcare infrastructure in emerging economies, and increasing investments in biotechnology and pharmaceutical research. Major trends in the forecast period include the development of rapid point-of-care diagnostics, the adoption of AI-driven predictive analytics, personalized antibiotic stewardship programs, advancements in blood culture techniques, innovative biomarker identification, and the development of novel therapies targeting immune modulation.
The growing prevalence of infectious diseases is expected to drive the expansion of the sepsis market in the coming years. Infectious diseases, caused by bacteria, viruses, fungi, or parasites, can spread through direct contact, contaminated sources, or insect vectors. Common examples include tuberculosis, influenza, ringworm, and malaria. Several factors contribute to the increasing incidence of infectious diseases, including globalization, environmental changes, drug-resistant pathogens, and gaps in healthcare systems. Sepsis, a severe complication of infections, results from the body's extreme response, leading to widespread inflammation and potential organ failure. For example, in November 2024, the Centers for Disease Control and Prevention reported that the United States recorded 9,633 cases of tuberculosis (TB) in 2023, marking a 15.6% increase from the 8,332 cases reported in 2022. Consequently, the rising burden of infectious diseases is fueling the growth of the sepsis market.
Companies in the sepsis market are leveraging advanced technology, such as artificial intelligence (AI)-powered platforms, to improve early diagnosis, enhance treatment precision, and predict patient outcomes. These innovations aim to reduce mortality rates and enhance healthcare efficiency in managing sepsis. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched OpenDX, an AI-powered diagnostic platform integrating wearable biosensors to detect early signs of sepsis. This technology aids in sepsis diagnosis and has the potential for application in other medical conditions, highlighting the increasing role of AI in diagnostics. Predicate's chest sensor enables healthcare professionals to identify early indicators of sepsis, a condition that is often challenging to diagnose.
In April 2024, Prenosis Inc., a US-based biotechnology research company, partnered with Roche Holding AG to advance sepsis diagnosis and management through AI-driven technology. As part of the partnership, Roche will distribute Prenosis' Sepsis ImmunoScore, an AI-based medical software designed to assist healthcare providers in rapidly diagnosing sepsis and predicting adverse outcomes. This collaboration enhances clinical sepsis management by integrating AI technology into healthcare settings. Roche Holding AG is a Switzerland-based pharmaceutical company specializing in oncology, immunology, infectious diseases, and other medical fields.
Major players in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMerieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.
North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sepsis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sepsis market includes revenues earned by entities by providing services such as blood culture testing, molecular diagnostics, biomarker testing, intravenous (IV) fluid management, organ support services, and tele-ICU services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sepsis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sepsis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sepsis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Diagnosis; Therapeutics
- 2) By Pathogen: Bacterial; Viral; Fungal
- 3) By Application: Severe Sepsis; Septic Shock
- 4) By End User: Hospitals; Pathology; Reference Laboratories
- Subsegments:
- 1) By Diagnosis: Blood Tests; Imaging Techniques; Microbiological Culture Tests; Biomarker Tests; Other Diagnostic Methods
- 2) By Therapeutics: Antibiotics; Antifungal Agents; Vasopressors; Immunoglobulins; Corticosteroids; Other Therapeutic Options
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck KGaA; Bayer AG; Thermo Fisher Scientific Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sepsis Market Characteristics
3. Sepsis Market Trends And Strategies
4. Sepsis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Sepsis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Sepsis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Sepsis Market Growth Rate Analysis
- 5.4. Global Sepsis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Sepsis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Sepsis Total Addressable Market (TAM)
6. Sepsis Market Segmentation
- 6.1. Global Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnosis
- Therapeutics
- 6.2. Global Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacterial
- Viral
- Fungal
- 6.3. Global Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Severe Sepsis
- Septic Shock
- 6.4. Global Sepsis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Pathology
- Reference Laboratories
- 6.5. Global Sepsis Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Tests
- Imaging Techniques
- Microbiological Culture Tests
- Biomarker Tests
- Other Diagnostic Methods
- 6.6. Global Sepsis Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antibiotics
- Antifungal Agents
- Vasopressors
- Immunoglobulins
- Corticosteroids
- Other Therapeutic Options
7. Sepsis Market Regional And Country Analysis
- 7.1. Global Sepsis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Sepsis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sepsis Market
- 8.1. Asia-Pacific Sepsis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sepsis Market
- 9.1. China Sepsis Market Overview
- 9.2. China Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sepsis Market
- 10.1. India Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sepsis Market
- 11.1. Japan Sepsis Market Overview
- 11.2. Japan Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sepsis Market
- 12.1. Australia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sepsis Market
- 13.1. Indonesia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sepsis Market
- 14.1. South Korea Sepsis Market Overview
- 14.2. South Korea Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sepsis Market
- 15.1. Western Europe Sepsis Market Overview
- 15.2. Western Europe Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sepsis Market
- 16.1. UK Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sepsis Market
- 17.1. Germany Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sepsis Market
- 18.1. France Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sepsis Market
- 19.1. Italy Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sepsis Market
- 20.1. Spain Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sepsis Market
- 21.1. Eastern Europe Sepsis Market Overview
- 21.2. Eastern Europe Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sepsis Market
- 22.1. Russia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sepsis Market
- 23.1. North America Sepsis Market Overview
- 23.2. North America Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sepsis Market
- 24.1. USA Sepsis Market Overview
- 24.2. USA Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sepsis Market
- 25.1. Canada Sepsis Market Overview
- 25.2. Canada Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sepsis Market
- 26.1. South America Sepsis Market Overview
- 26.2. South America Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sepsis Market
- 27.1. Brazil Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sepsis Market
- 28.1. Middle East Sepsis Market Overview
- 28.2. Middle East Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sepsis Market
- 29.1. Africa Sepsis Market Overview
- 29.2. Africa Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sepsis Market Competitive Landscape And Company Profiles
- 30.1. Sepsis Market Competitive Landscape
- 30.2. Sepsis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Sepsis Market Other Major And Innovative Companies
- 31.1. Abbott laboratories
- 31.2. Novartis AG
- 31.3. Siemens AG
- 31.4. Asahi Kasei Corporation
- 31.5. Becton, Dickinson and Company
- 31.6. bioMerieux SA
- 31.7. QuidelOrtho Corporation
- 31.8. Diasorin S.p.A.
- 31.9. Innoviva Inc.
- 31.10. Seegene Inc.
- 31.11. EKF Diagnostics
- 31.12. Boditech Med Inc.
- 31.13. Cytovale Inc.
- 31.14. Alifax S.r.l.
- 31.15. Hansa Biopharma
32. Global Sepsis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sepsis Market
34. Recent Developments In The Sepsis Market
35. Sepsis Market High Potential Countries, Segments and Strategies
- 35.1 Sepsis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Sepsis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Sepsis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
